Everyday Health

Treatment for Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a bleeding disorder in which there is a shortage of platelets, the blood cells responsible for clotting, according to MedlinePlus. The condition typically results when ...
Self

Chronic ITP Treatment: What You Need to Know

This might sound surprising, but getting diagnosed with immune thrombocytopenia (also known as idiopathic thrombocytopenic purpura, or ITP) can come as a relief. You can figure out ITP treatment, of ...

Ouro Medicines Receives U.S. FDA Fast Track Designation for Gamgertamig in Immune Thrombocytopenia and Autoimmune Hemolytic Anemia

Ouro Medicines, a clinical stage biotechnology company developing immune reset therapeutics for people living with chronic, ...
MedPage Today

Immune Thrombocytopenia Treatment Patterns: In-line with Guidelines?

"The treatment paradigm of ITP is slowly shifting due to expanding experience with earlier use of TPO-RAs and TPO-mimetics in chronic and refractory ITP…Most of these agents are oral and better ...
Healthline

Ask the Expert: Managing Your Idiopathic Thrombocytopenic Purpura Treatment

There are several types of effective treatments for ITP to raise platelet counts and reduce the risk of serious bleeding. Steroids. Steroids are often used as a first-line treatment. They suppress the ...
The Vindicator

Patient’s options to treat ITP are many

DEAR DR. ROACH: What can you tell me about the cause and treatment of immune thrombocytopenia purpura (ITP)? I am a 71-year-old male, and after lab results showed a low blood platelet count, I ...
MedPage Today

ITP in Children: What Triggers Second-Line Treatment?

New prospective research builds on a previous study that showed guidelines aren’t the main driver of treatment selection in pediatric patients with ITP. Of 12 potential reasons for prescribing ...
The American Journal of Managed Care

Practical Considerations for ITP Therapy Selection and Future Research

An expert discusses how rilzabrutinib uniquely improves quality-of-life metrics, including fatigue and women’s health domains, which previous immune thrombocytopenia (ITP) therapies failed to address ...
The American Journal of Managed Care

Addressing the Limitations of Current ITP Therapies

An expert discusses the importance of patient education and personalized, flexible treatment planning in managing chronic immune thrombocytopenic purpura (ITP), highlighting proactive strategies like ...
Nasdaq

Fostamatinib Meets Primary Endpoint in Phase 3 Trial in Japan for Treatment of Chronic Immune Thrombocytopenia

SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that its collaboration partner, Kissei ...
Healthline

ITP and COVID-19: Risks, Concerns, and How to Protect Yourself

The COVID-19 pandemic has reshaped daily life around the world. For many people living with chronic health conditions, the pandemic has been especially concerning. COVID-19 is a contagious respiratory ...